Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilensky, A. J.
Right arrow Articles by Dodrill, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilensky, A. J.
Right arrow Articles by Dodrill, C. B.
NEUROLOGY 1981;31:1271
© 1981 American Academy of Neurology

Clorazepate and phenobarbital as antiepileptic drugs

A double-blind study

Alan J. Wilensky, M.D., Linda Moretti Ojemann, M.D., Nancy R. Temkin, Ph.D., Allan S. Troupin, M.D. and Carl B. Dodrill, Ph.D.

Regional Epilepsy Center, Department of Neurological Surgery, School of Medicine, University of Washington, Seattle, WA.

The antiepileptic effect of clorazepate when given with phenytoin was compared, in a randomized double-blind crossover study, to the effect of the standard regimen of phenobarbital plus phenytoin in patients with partial seizures. Thirty of 42 subjects preferred the clorazepate-phenytoin regimen (p <0.01). The same number of subjects had fewer seizures while taking clorazepate as had fewer seizures while taking phenobarbital. However, subjects had significantly more toxicity, objective and subjective, on the phenobarbital-phenytoin regimen (p <0.01 in both cases). In some subjects, increased toxicity due to phenobarbital outweighed better seizure control, so that clorazepate was preferred. As an add-on antiepileptic drug, clorazepate is well tolerated, effective, and preferred by most patients to phenobarbital.

Address correspondence and reprint requests to Dr. Wilensky, Epilepsy Center ZA-50, Harborview Medical Center, Seattle, WA 98104.

This study was supported by NIH Contracts N01-NS-0-2281 and N01-NS-6-2341, awarded by the National Institute of Neurological and Cornrnunicative Disorders and Stroke.

Presented in part at the thirty-first annual meeting of the American Academy of Neurology, Chicago, IL, April 1979.

Accepted for publication February 4, 1981.




This article has been cited by other articles:


Home page
Arch NeurolHome page
J. B. Shofer and N. R. Temkin
Comparison of Alternative Outcome Measures for Antiepileptic Drug Trials
Arch Neurol, September 1, 1986; 43(9): 877 - 881.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.